Lung Cancer Clinical Trials in Shanghai
10 recruitingShanghai, China
Showing 1–10 of 10 trials
Recruiting
Phase 1
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Pancreatic CancerLung CancerGastrointestinal Cancer
Boehringer Ingelheim97 enrolled7 locationsNCT06091930
Recruiting
Phase 1
A Study of GC203 TIL in Advanced Malignant Solid Tumors
Breast CancerLung CancerSolid Tumor+2 more
Shanghai Juncell Therapeutics18 enrolled1 locationNCT06375187
Recruiting
Phase 2Phase 3
Trop2-targeted immunoPET Imaging of Solid Tumors
Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Phase 1Phase 2
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Lung CancerNon-small Cell Lung Cancer
Daiichi Sankyo137 enrolled45 locationsNCT06644768
Recruiting
Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Lung Cancer
Geneplus-Beijing Co. Ltd.100 enrolled1 locationNCT05965557
Recruiting
Not Applicable
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Lung CancerLung NeoplasmsLung Cancer Metastatic+2 more
RenJi Hospital100 enrolled1 locationNCT07026110
Recruiting
Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
Lung CancerMyocarditis Due to Drug
Shanghai Chest Hospital50 enrolled1 locationNCT06818149
Recruiting
Phase 2
Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expression
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China58 enrolled1 locationNCT06749860
Recruiting
Phase 2
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China22 enrolled1 locationNCT06749886
Recruiting
Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China2,000 enrolled1 locationNCT05857800